The S&P 500 barely managed a record closing high on Tuesday, its fifth straight day of gains with investor optimism ahead of megacap earnings reports being countered by a mixed reception to the latest ...
Over the past week, health insurers have drawn the ire of lawmakers on both sides of the aisle and seen their collective stock prices drop by nearly $100 billion following unfavorable Medicare ...
The Trump administration’s proposed update to its Medicare payment policies could affect larger Medicare Advantage companies ...
A tiny pay raise and new restrictions for Medicare Advantage plans show the administration won't go easy on the industry.
Although hospital-owned plans are only a sliver of the Medicare Advantage market, their enrollment continues to grow, ...
We recently published 10 Big Names With Painful Declines. Humana Inc. (NYSE:HUM) was one of the worst performers on Tuesday.
The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...
Humana stock plunged 21% after a shockingly low Medicare Advantage rate proposal threatens margins and clouds the insurer’s ...
CMS's proposed 0.09% Medicare Advantage rate hike for 2027 triggered a sharp sell-off across US health insurers, signaling ...
That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.
Humana, a Kentucky-based, publicly traded medical insurer, offers Medicare Advantage plans in Hawaiʻi. Such plans are funded ...
The threat of virtually no payment rate increases next year for Medicare Advantage plans sent managed care organizations, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results